Structural determinants for high-affinity zolpidem binding to GABA-A receptors

Area of Science:

• Neuroscience
• Pharmacology
• Molecular Biology

Background:

• Zolpidem (Ambien) is a widely prescribed imidazopyridine sleep aid.
• It binds to the GABA-A receptor (GABAR), similar to benzodiazepines (BZDs).
• Zolpidem's distinct structure suggests different binding requirements than classic BZDs.

Purpose of the Study:

• To identify additional gamma-2 subunit residues essential for high-affinity zolpidem binding to GABARs.
• To elucidate the structural basis for zolpidem's specific interaction with the GABAR.

Main Methods:

• Radioligand binding assays
• Construction and testing of gamma-2/alpha-1 chimeric GABAR subunits
• Site-directed mutagenesis
• Molecular modeling and in silico zolpidem docking

Main Results:

• A seven-amino acid stretch (residues 186-192) in the gamma-2 subunit loop F region is critical for high-affinity zolpidem binding.
• This loop F region is located at the alpha/gamma subunit interface.
• Specific residues (gamma2Glu189, gamma2Thr193, gamma2Arg194) within loop F are important for stabilizing zolpidem in the binding pocket.

Conclusions:

• The gamma-2 subunit loop F region plays a key role in conferring high-affinity binding for zolpidem.
• These findings highlight structural differences in GABAR binding between zolpidem and classic BZDs.
• Identified residues provide insights into the molecular mechanism of zolpidem action.